Advertisement

Patient Safety & Outcomes

Rolapitant, a potent, selective NK1 receptor antagonist, reduces the incidence of vomiting in a dose-dependent manner after surgery, according to a study published in the March 2011 issue of Anesthesia & Analgesia.

Advertisement

On March 2, leadership from the American Society of Anesthesiologists met with CMS administrator Don Berwick, MD, MPP, and other CMS staff members to discuss patient safety, meaningful use and payment issues, according to an ASA news release.

More research is needed to determine whether minimizing anesthetic exposure will improve outcomes in vulnerable patients, according to a study published in Anesthesiology that examined the effect of anesthesia depth on long-term mortality.

Despite the common belief an appendicitis needs to be treated right away, recent studies are showing most cases don't need to be rushed to the operating room, according to a USA Today news report.

Advertisement